NCT06703684Completed
TCM Syndrome Differentiation of T2DM & MetS
TCM Syndrome Differentiation of Type 2 Diabetes Comorbid With Metabolic Syndrome
Source: ClinicalTrials.gov · Last updated 31 Mar 2026
Brief summary (registry, in English)
This study aims to include type 2 diabetes (T2DM) patients comorbid with metabolic syndrome (MetS). The primary aim of the study is to investigate the TCM (Traditional Chinese Medicine) syndrome differentiation of T2DM comorbid with MetS.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 470 (actual)
- First submitted
- 17 Nov 2024
- Start date
- 20 Nov 2024
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Hong Kong Baptist University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06703684
What you commit to
- Study type: Observational
- Participants enrolled: 470
- From 20 Nov 2024 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (1) Diagnosed with type 1 diabetes, steroid-induced diabetes, gestational diabetes, or specific types of diabetes.
- (2) Diabetes accompanied by severe complications such as diabetic nephropathy, diabetic ketoacidosis, etc.
- (4) Secondary hypertension (e.g., pheochromocytoma, renal hypertension, etc.).
- (5) Secondary hyperlipidemia (e.g., hypothyroidism, nephrotic syndrome, etc.).
- (6) With severe heart, liver, or kidney disease or bleeding disorders, or with other serious diseases (e.g. cancer, dementia, etc.).
- (7) With severe mental disorders, speech or hearing impairments.
Other
- (3) Secondary obesity (e.g., secondary to pituitary inflammation, tumor, etc.).
- (8) Pregnancy or lactation female.
- (9) Currently join other clinical trial.
Who the study is looking for
- (1) Age between 18-75y.
- (2) Diagnosed with Type 2 diabetes.
- (3) Diagnosed with Metabolic Syndrome according to Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) from Chinese Diabetes Society. People who meet 3 of the following diagnostic criteria or more can be diagnosed as Metabolic Syndrome: (a) Abdominal obesity: waist circumference ≥ 90cm for male and ≥ 85cm for female; (b) Hyperglycemia: Fasting blood glucose ≥ 6.1mmol/L or 2-hour postprandial glucose ≥ 7.8mmol/L and/or those who have been diagnosed with hyperglycemia and in treatment; (c) Hypertension: blood pressure ≥ 130/85mmHg and/or those who have been diagnosed with hypertension and in treatment; (d) Fasting triglyceride ≥ 1.70mmol/L; (e) Fasting HDL-C \< 1.04mmol/L.
- (4) Clearly understand the content of the study and voluntarily sign the informed consent form.
- (5) Provide complete data (basic information, TCM diagnosis data, and blood test results).
Age in the registry: 18 years to 75 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hong Kong Baptist University Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
Related publications
- Traditional Chinese medicine syndrome patterns and associated factors in adults with type 2 diabetes and metabolic syndrome: a data-driven analysis.Front Endocrinol (Lausanne) · 2026 · PMID 42388871
- Traditional Chinese Medicine Syndrome Differentiation of Adult Patients With Type 2 Diabetes and Metabolic Syndrome: Protocol for a Cross-Sectional Study.JMIR Res Protoc · 2026 · PMID 41576380
This page is information, not medical advice. Discuss any trial with your doctor.